PATENT CLAIM ANALYSIS

Application Number: 15977572
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "001300"]

Abstract:
The invention described herein pertains to the diagnosis, imaging, and/or treatment of pathogenic cell populations. In particular, the invention described herein pertains to the diagnosis, imaging, and/or treatment of diseases caused by PSMA expressing cells, such as prostate cancer cells, using compounds capable of targeting PSMA expressing cells.

Claim (Index 41):
The conjugate of  claim 35 , wherein the at least three amino acids are each independently D-phenylalanine, D-tyrosine or D-lysine, wherein each hydrogen atom on the amino acid side chain is independently optionally substituted with an amino, hydroxy, halo, thio, alkyl, haloalkyl, heteroalkyl, aryl, arylalkyl, arylheteroalkyl, heteroaryl, heteroarylalkyl, heteroarylheteroalkyl, nitro, or sulfonic acid group.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 93.0
- Lexical Diversity: 1.72727
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14443212', '15245505', '15606913', '12530952', '15959110']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7459551456701685
- 35 USC 102 Novelty (BERT): 0.5429568313761071
- Combined Prediction Score: 0.7256553142407624
- Mean Citation Score: 320.46455
- Max Citation Score: 390.5377
- Similarity Product: 259.6839751290977

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test